PRQR: Reports Positive Phase 1 Data
ProQR announces positive phase 1 target engagement data for AX-0810, validating the Axiomer RNA editing platform
PRQR - ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform